Policy on Transparency

Basic Philosophy

Kitazato Corporation recognizes that, as a company engaged in reproductive medicine, ensuring transparency in its relationships with medical institutions, research organizations, and other stakeholders is essential for building trust with society.

Guided by our corporate philosophy, “Happiness, for the Next Generations,” our business activities are conducted with a high standard of ethics and integrity. We strive to contribute to the advancement of medicine and science, as well as to all those involved in fertility treatment.

This Policy aims to enhance transparency by appropriately disclosing information related to financial support and collaborative activities with relevant parties, thereby fostering a broad understanding that our corporate activities are conducted fairly and ethically.

Method and Timing of Disclosure

For each fiscal year (from April 1 to March 31 of the following year), information regarding financial contributions and related activities will be disclosed on our website within one year following the end of the fiscal year.

Scope of Disclosure

We disclose the details and annual results of financial contributions and related support in the following categories.

A. Research and Development Expenses

Expenses are provided to support research and development related to fertility treatment and reproductive medicine. The recipients and the total annual amounts are disclosed.

• Basic research expenses
• Post-marketing surveillance and study expenses, and other related costs

B. Academic Research Grants

Details of support provided for the promotion of academic research in the field of reproductive medicine, including donations and sponsorship of academic societies.

• Scholarship donations
• General donations
• Donations to academic societies
• Co-hosting and sponsorship expenses for academic societies, and other related activities

Commitment to Ensuring Transparency

Kitazato Corporation is committed to accurately and sincerely disclosing information that should be made public and to maintaining transparency and accountability to all stakeholders.

• Compliance with laws and industry standards 
• Thorough prevention of conflicts of interest 
• Corporate activities that place a strong emphasis on ethics    
• Awareness of social responsibility in relation to fertility treatment 

Through these efforts, we aim to achieve sustainable growth as a company trusted by society.

Conclusion

As a company engaged in reproductive medicine, we recognize ensuring transparency as a vital social responsibility.

We will continue to conduct our business activities with integrity and openness, thereby further strengthening trust as a company that contributes to future generations and new life.